A stepwise approach can be best. Here are seven rules to follow.
Long
Many patients will receive a life-changing diagnosis at some point, whether that be a chronic illness or cancer.
An increasing number of women are receiving breast cancer diagnoses over the phone, according to a new study from the University of Missouri School of Medicine. Prior to 2006, most breast cancer diagnoses were communicated in person. Since 2006, over half of diagnoses were given over the phone and between 2015 to 2017, almost 60% learned of their diagnosis over the phone. This study shows how women received the news, but did not ask what their preferences would be, or the impact-if any-on their cancer experience.
This evolution is due in part to increased demand from patients to receive news about their health faster, which is now the norm rather than the exception in healthcare.
“This study highlights a shift in how many patients are informed of breast cancer diagnoses,” says Natalie Long, MD, University of Missouri School of Medicine, who was not directly involved in the actual research project but rather works in medical student education with the School of Medicine. “Rather than routinely receiving the news in the physician’s office, many are now learning of a breast cancer diagnosis over the phone. This has implications on patient satisfaction and also how a patient may navigate through the health system. Advancing technology and a fast-paced digital lifestyle are changing societal norms as well as how we communicate and healthcare will need to adapt as well.”
The trend has prompted the University of Missouri School of Medicine to develop new training methods to better prepare future physicians to deliver negative news without being face-to-face with patients.
“When delivering bad news, such as breast cancer, taking a stepwise approach can help the physician deliver the news in a caring yet informative manner,” says Long.
Seven ways
Long offers seven ways to help healthcare providers deliver life-changing news to patients:
CAR T-Cell Therapy Cuts Costs, Reduces Treatment in Mantle Cell Lymphoma
March 13th 2025In a real-world study, researchers found this data by comparing treatment patterns, healthcare resource utilization, and costs between patients receiving CAR T-cell therapy and those treated with the non-CAR T standard of care.
Read More
FDA Approves Tevimbra for Advanced Esophageal Cancer at $15,828 Per Month
March 5th 2025Esophageal squamous cell carcinoma accounts for approximately 90% of all esophageal cancer cases. Projections estimate that by 2040, there will be approximately 957,000 new cases of esophageal cancer worldwide, marking a nearly 60% increase from 2020, according to BeiGene.
Read More
In the Scope of Virtual Health and the Future of “Website” Manner, Per Ateev Mehrotra
August 10th 2023Briana Contreras, an editor of Managed Healthcare Executive, had the pleasure of catching up with MHE Editorial Advisory Board Member, Ateev Mehrotra, MD, MPH, who is a professor of healthcare policy at Harvard Medical School and an Associate Professor of Medicine and Hospitalist at Beth Israel Deaconess Medical Center.
Listen
CIBMTR Ranks Cedars-Sinai Cancer Among Top Transplant Programs in the U.S.
February 9th 2025Cedars-Sinai was one of 12 among 172 adult transplant centers in the U.S. with a one-year patient post-transplant survival rate above the expected outcome. In 2024, the survival rate for Cedars-Sinai was 90% versus the expected rate of 68% to 83%.
Read More